GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative ...

On Tuesday 11 February 2025, Luxembourg’s Chamber of Employees (Chambre des Salariés - CSL) presented the results of an ...

The Pan American Health Organization (PAHO) has issued an epidemiological alert regarding the increased risk of dengue ...

This article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...